Khaitan Chemicals & Fertilizers Ltd
KHAICHEMKhaitan Chemicals & Fertilizers Ltd is cheap for a reason. The P/E sits at the 17th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: annual EPS moved +4,657.1% against a −52.7% price move — the market has not yet caught up with the delivery.
The price is in a downtrend (30 weeks in) while the P/E sits at the 17th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −47.6% year on year, and 0% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Khaitan Chemicals & Fertilizers Ltd trades at ₹49.0, in a downtrend and 30 weeks into that stage. That is −25.7% against its own 200-day average. It sits at 4% of a 52-week range of ₹46 to ₹129. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is in a downtrend — week 30 of stage 4, confirmed. At ₹49.0 it trades −25.7% versus its 200-day average and sits at 4% of its 52-week range (₹46–₹129).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +487% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Khaitan Chemicals & Fertilizers Ltd trades at 8.7× P/E, near the bottom of its own range — cheaper only 17% of the time. Its long-run median P/E is 15.4×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 8.7× is near the bottom of its own range — cheaper only 17% of the time, against a long-run median of 15.4× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +4,657.1% against a −52.7% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −4.8%/yr price move, ~+9.2%/yr came from earnings growth and ~−14.0 pp from the multiple (compressing); over 10y, of the +16.7%/yr price move, ~+44.6%/yr came from earnings growth and ~−27.9 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Khaitan Chemicals & Fertilizers Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +39.2% | +4.1% | +15.8% | +9.8% |
| Profit | +6,400.0% | +15.7% | +21.1% | +41.6% |
| EPS | +4,657.1% | +15.3% | +21.1% | +44.3% |
| Share price | −52.7% | −9.3% | −4.8% | +16.7% |
4-Factor Sector Score
51.8/100 — rank 7 of 15 in Fertilisers · 74% evidence confidence
Khaitan Chemicals & Fertilizers Ltd scores 51.8 out of 100 against the 15 companies it is compared with in Fertilisers, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 21.6 + 15.6 + 10.8 + 3.8 = 51.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Khaitan Chemicals & Fertilizers Ltd reported ₹221 Cr of revenue in the Jun 26 quarter, −5.6% year on year. Over 10 years it has compounded at 9.8% a year. The last full year, FY26, came in at ₹1,002 Cr. The last four reported quarters add to ₹989 Cr.
FY26 revenue came in at ₹1,002 Cr (+39.2% on the year), capping 10 years at 9.8% compound. The latest quarter (Jun 26) printed ₹221 Cr, −5.6% year on year.
Pace check: the last four quarters averaged +20.5% growth against the decade's 9.8% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +19.9% over the last 4 quarters against +40.5%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Khaitan Chemicals & Fertilizers Ltd's operating margin is 11.0% in the Jun 26 quarter, −3.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −6.0% to 15.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 11.0%, −3.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −6.0%–15.0%.
🚨 Why the margin moved: operating margin went −2.9 pp year on year while gross margin went −10.8 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Khaitan Chemicals & Fertilizers Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter, −47.6% year on year. Full-year FY26 profit was ₹65.0 Cr. The 10-year compound rate is 41.6%. That is 5.0% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr. 4 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹11.0 Cr, −47.6% year on year. On the full year, FY26 printed ₹65.0 Cr (+6,400.0%), and the 10-year compound rate is 41.6%.
🚨 Why profit moved: revenue contributed −5.6% and the margin −3.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −27.6% vs revenue +20.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 0% of Khaitan Chemicals & Fertilizers Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹44.0 Cr of operating cash against ₹65.0 Cr of profit. After ₹3.0 Cr of capital spending, ₹41.0 Cr was left as free cash.
FY26: operating cash of ₹44.0 Cr against reported profit of ₹65.0 Cr, leaving free cash of ₹41.0 Cr after ₹3.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 0% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 0%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Khaitan Chemicals & Fertilizers Ltd's cash conversion cycle runs 119 days in FY26, down from 124 days in FY21. Capital spending ran ₹22.0 Cr over the last 3 years. At FY26 sales of ₹1,002 Cr each day of that cycle holds about ₹2.7 Cr, so roughly ₹327 Cr sits inside the business at any moment.
FY26: debtors at 23 days, inventory at 128 days — roughly 4.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 119 days, tighter than FY21's 124.
The full loop: cash goes out to suppliers and production on day 0; stock waits 128 days to sell; customers pay about 23 days after that; and suppliers themselves are paid at 31 days — netting out to the 119-day cycle.
In money terms: at FY26 sales of ₹1,002 Cr, each day of the cycle holds about ₹2.7 Cr — so the 119-day loop keeps roughly ₹327 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹22.0 Cr over the last 3 fiscal years against ₹33.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹3.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Khaitan Chemicals & Fertilizers Ltd earns a ROCE of 18% in FY26. That is up from a trough of −8% in FY24. Return on invested capital clears the cost of that capital by +6.1 percentage points, so growth here adds value rather than only size. The wiring behind it is 6.5% net margin on 1.47× asset turns.
FY26 ROCE is 18%, recovered from a FY24 trough of −8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 6.5% net margin × 1.47× asset turns × 2.35× balance-sheet leverage ≈ 22.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 18.1% − 12.0% = a +6.1 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. A spread this wide means every rupee reinvested creates more than a rupee of value — the engine compounds.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Khaitan Chemicals & Fertilizers Ltd carries ₹306 Cr of borrowings against ₹291 Cr of equity in FY26, a debt-to-equity of 1.05. Operating profit covers the interest bill 4×. Over 5 years borrowings went from ₹79.0 Cr to ₹306 Cr. Capital spending ran ₹22.0 Cr across the last 3 of those years.
FY26: borrowings of ₹306 Cr against equity of ₹291 Cr — a debt-to-equity of 1.05. Operating profit covers the interest bill 4×. Over 5 years borrowings went from ₹79.0 Cr to ₹306 Cr while capital spending ran ₹22.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 2.3 points of Khaitan Chemicals & Fertilizers Ltd over 8 quarters, the biggest move on the register. That takes promoters to 72.7% of the company. Foreign institutions moved +0.0 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −2.3 points over 8 quarters to 72.7%; Foreign institutions: +0.0 points over 8 quarters to 0.1%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.
🚨 Why the register moved: promoters drove it (−2.3 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Khaitan Chemicals & Fertilizers Ltd: the Z-score reads 4.05. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 4.05 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 4.05.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Krishana Phoschem LtdKRISHANA | 72.4/100Favorable setup100% evidence | ASLEEP | 29.8/35 Revenue 73.3% · PAT 92.2% · OPM change 0 pp 100% evidence | 19.0/25 ROCE 27.2% · OPM 17% 100% evidence | 13.5/20 P/E 30× · PEG 0.58 100% evidence | 10.1/20 RS sector -55.6% · RS bench 49.5% · 1Y -65.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 29.8 + 19 + 13.5 + 10.1 = 72.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Gujarat Narmada Valley Fertilizers & Chemicals LtdGNFC | 67.8/100Favorable setup100% evidence | FADING | 24.9/35 Revenue 12.6% · PAT 84.5% · OPM change 16.1 pp 100% evidence | 13.4/25 ROCE 12% · OPM 18% 100% evidence | 15.5/20 P/E 8.1× · PEG 0.27 100% evidence | 14.0/20 RS sector 16.2% · RS bench 7% · 1Y 7.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 24.9 + 13.4 + 15.5 + 14 = 67.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Chambal Fertilisers & Chemicals LtdCHAMBLFERT | 64.6/100Mixed-positive evidence100% evidence | ASLEEP | 17.9/35 Revenue 15.6% · PAT 10.2% · OPM change 3 pp 100% evidence | 19.3/25 ROCE 25.2% · OPM 16% 100% evidence | 16.9/20 P/E 9.2× · PEG 0.52 100% evidence | 10.5/20 RS sector 2.5% · RS bench -5.9% · 1Y -15.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 19.3 + 16.9 + 10.5 = 64.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Madhya Bharat Agro Products LtdMBAPL | 56.4/100Mixed-positive evidence100% evidence | ASLEEP | 25.0/35 Revenue 47.6% · PAT 100% · OPM change 2 pp 100% evidence | 16.1/25 ROCE 19.3% · OPM 16% 100% evidence | 3.9/20 P/E 47.6× · PEG 2.04 100% evidence | 11.4/20 RS sector -53.1% · RS bench 57.9% · 1Y -62.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 25 + 16.1 + 3.9 + 11.4 = 56.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Rashtriya Chemicals & Fertilizers LtdRCF | 53.6/100Mixed-positive evidence94% evidence | ASLEEP | 24.6/35 Revenue 17.5% · PAT 56.8% · OPM change 1.3 pp 100% evidence | 7.7/25 ROCE 10.2% · OPM 6% 100% evidence | 12.1/20 P/E 16.4× · PEG 0.9 100% evidence | 9.2/20 RS sector -3.1% · RS bench -8.8% · 1Y -13.5%3 of 10 weeks ahead 70% evidence |
| Exact sum: 24.6 + 7.7 + 12.1 + 9.2 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Paradeep Phosphates LtdPARADEEP | 52.6/100Mixed-positive evidence69% evidence | TURNING | 21.1/35 Revenue 28.1% · PAT 12.6% · OPM change -1 pp 95% evidence | 14.2/25 ROCE 17.1% · OPM 12% 76% evidence | 9.7/20 P/E 14.1× · PEG — 15% evidence | 7.6/20 RS sector -12.4% · RS bench -1.2% · 1Y -33.5%7 of 10 weeks ahead 70% evidence |
| Exact sum: 21.1 + 14.2 + 9.7 + 7.6 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Khaitan Chemicals & Fertilizers Ltdthis pageKHAICHEM | 51.8/100Mixed-positive evidence74% evidence | 21.6/35 Revenue 19.9% · PAT 32.5% · OPM change -3 pp 95% evidence | 15.6/25 ROCE 18.5% · OPM 11% 95% evidence | 10.8/20 P/E 8.7× · PEG — 15% evidence | 3.8/20 RS sector -31.3% · RS bench -38.4% · 1Y -53.2%1 of 7 weeks ahead 70% evidence | |
| Exact sum: 21.6 + 15.6 + 10.8 + 3.8 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Zuari Agro Chemicals LtdZUARI | 47.7/100Mixed-negative evidence81% evidence | ASLEEP | 16.9/35 Revenue -44% · PAT 100% · OPM change -1 pp 95% evidence | 10.0/25 ROCE 16.4% · OPM 10% 95% evidence | 14.6/20 P/E 3× · PEG — 50% evidence | 6.2/20 RS sector -6.9% · RS bench -13.5% · 1Y -37.2%2 of 10 weeks ahead 70% evidence |
| Exact sum: 16.9 + 10 + 14.6 + 6.2 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Gujarat State Fertilizers & Chemicals LtdGSFC | 46.9/100Mixed-negative evidence94% evidence | ASLEEP | 18.0/35 Revenue 29.2% · PAT 7.8% · OPM change -3 pp 100% evidence | 6.0/25 ROCE 7.2% · OPM 6% 100% evidence | 15.0/20 P/E 9.2× · PEG 0.3 100% evidence | 7.9/20 RS sector -5.5% · RS bench -10.8% · 1Y -24.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18 + 6 + 15 + 7.9 = 46.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Coromandel International LtdCOROMANDEL | 46.0/100Mixed-negative evidence94% evidence | TURNING | 13.8/35 Revenue 23.5% · PAT -20.9% · OPM change -2 pp 100% evidence | 17.2/25 ROCE 22% · OPM 9% 100% evidence | 1.3/20 P/E 33.1× · PEG 2.69 100% evidence | 13.7/20 RS sector 5% · RS bench -5.5% · 1Y -14.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.8 + 17.2 + 1.3 + 13.7 = 46 · Decision use: Price leads the evidence: RS versus the benchmark is -5.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11Deepak Fertilisers & Petrochemicals Corp LtdDEEPAKFERT | 45.8/100Mixed-negative evidence94% evidence | TURNING | 13.5/35 Revenue 13.6% · PAT -0.5% · OPM change 7 pp 100% evidence | 12.1/25 ROCE 11.4% · OPM 26% 100% evidence | 10.6/20 P/E 19.2× · PEG 0.57 100% evidence | 9.6/20 RS sector -11.5% · RS bench 13.5% · 1Y 4.6%10 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 12.1 + 10.6 + 9.6 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12National Fertilizer LtdNFL | 43.7/100Mixed-negative evidence84% evidence | ASLEEP | 24.5/35 Revenue 23.3% · PAT 100% · OPM change 3.7 pp 74% evidence | 4.1/25 ROCE 9.1% · OPM 6% 100% evidence | 10.0/20 P/E 9.7× · PEG 1.39 65% evidence | 5.1/20 RS sector -6.7% · RS bench -14.7% · 1Y -22.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 4.1 + 10 + 5.1 = 43.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.7% and the one-year return is -22.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 13Southern Petrochemicals Industries Corporation LtdSPIC | 43.1/100Mixed-negative evidence80% evidence | ASLEEP | 11.2/35 Revenue -2.9% · PAT 28.3% · OPM change -5 pp 95% evidence | 14.6/25 ROCE 17.5% · OPM 7% 95% evidence | 11.3/20 P/E 6.7× · PEG — 15% evidence | 6.0/20 RS sector -6.7% · RS bench -15.2% · 1Y -21.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 11.2 + 14.6 + 11.3 + 6 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Fertilizers & Chemicals Travancore LtdFACT | 32.2/100Adverse evidence75% evidence | ASLEEP | 9.0/35 Revenue 32% · PAT -80% · OPM change -4.7 pp 100% evidence | 3.9/25 ROCE 4.9% · OPM -2.4% 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.3/20 RS sector 2.7% · RS bench -5.7% · 1Y -9.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 3.9 + 10 + 9.3 = 32.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Madras Fertilizers LtdMADRASFERT | 30.5/100Adverse evidence74% evidence | ASLEEP | 4.5/35 Revenue -4.5% · PAT 4.3% · OPM change -4 pp 95% evidence | 10.9/25 ROCE 14.8% · OPM 6% 95% evidence | 9.9/20 P/E 13.5× · PEG — 15% evidence | 5.2/20 RS sector -14.4% · RS bench -12.7% · 1Y -25.5%3 of 10 weeks ahead 70% evidence |
| Exact sum: 4.5 + 10.9 + 9.9 + 5.2 = 30.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Khaitan Chemicals & Fertilizers Ltd's share price today?
Khaitan Chemicals & Fertilizers Ltd trades at ₹49.0, −52.7% over the past year. The company is valued at ₹508 Cr. The stock sits at 4% of its 52-week range of ₹46–₹129, −25.7% versus its 200-day average. On the tape, the price is in a downtrend, 30 weeks in. — as of 14 August 2026.
What were Khaitan Chemicals & Fertilizers Ltd's latest quarterly results?
Khaitan Chemicals & Fertilizers Ltd reported revenue of ₹221 Cr and net profit of ₹11.0 Cr for the Jun 26 quarter. Revenue fell 5.6% and profit fell 47.6% year on year. Earnings per share were ₹1.12. The operating margin was 11.0%, 3.0 pp lower than a year earlier. — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's revenue?
Khaitan Chemicals & Fertilizers Ltd reported revenue of ₹221 Cr in the Jun 26 quarter, −5.6% year on year. For the full FY26 fiscal year, revenue was ₹1,002 Cr (+39.2%). Over the last 10 years revenue compounded at 9.8% a year. — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's profit?
Khaitan Chemicals & Fertilizers Ltd earned ₹11.0 Cr of net profit in the Jun 26 quarter, −47.6% year on year. Full-year FY26 profit was ₹65.0 Cr. The operating margin ran 11.0% in the latest quarter. — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's market cap?
Khaitan Chemicals & Fertilizers Ltd's market capitalisation is ₹508 Cr at a share price of ₹49.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's P/E ratio?
Khaitan Chemicals & Fertilizers Ltd trades at a P/E of 8.7×, at the 17th percentile of its own 11-year range, against a long-run median of 15.4×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Khaitan Chemicals & Fertilizers Ltd pay a dividend?
Yes — Khaitan Chemicals & Fertilizers Ltd's dividend payout was 1% of profit in FY26, and it recorded a payout in 10 of its last 13 reported fiscal years. One of those years shows a negative ratio because profit itself was negative. — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd overvalued?
On its own history, Khaitan Chemicals & Fertilizers Ltd looks cheap: its P/E of 8.7× has been cheaper only 17% of the time in 11 years (long-run median 15.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd growing?
Not right now — Khaitan Chemicals & Fertilizers Ltd's latest numbers are shrinking: latest-quarter revenue −5.6% year on year, profit −47.6%, and the margin −3.0 pp at 11.0%. The 10-year compound rates are 9.8% (revenue) and 41.6% (profit). The earnings engine currently reads: deteriorating — as of 14 August 2026.
How is Khaitan Chemicals & Fertilizers Ltd performing?
Khaitan Chemicals & Fertilizers Ltd is in a downtrend, 30 weeks in. Its latest quarter's revenue fell 5.6% and profit fell 47.6% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd in an uptrend?
No — the price is in a downtrend (week 30 of stage 4), trading −25.7% versus its 200-day average and at 4% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd beating the market?
Not lately — on a trailing-13-week view Khaitan Chemicals & Fertilizers Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +487% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 14 August 2026.
Will Khaitan Chemicals & Fertilizers Ltd's share price go up?
This page publishes no price forecast for Khaitan Chemicals & Fertilizers Ltd. What it measures instead: the share price is ₹49.0, the price is in a downtrend 30 weeks in. Its P/E of 8.7× sits at the 17th percentile of its own 11-year range. — as of 14 August 2026.
Who owns Khaitan Chemicals & Fertilizers Ltd?
Promoters hold 72.7% of Khaitan Chemicals & Fertilizers Ltd, foreign institutions 0.1%, domestic institutions null% and the public 27.2% (latest quarter). The biggest move on the register over the last two years: Promoters cut 2.3 points over 8 quarters. — as of 14 August 2026.
Does Khaitan Chemicals & Fertilizers Ltd have too much debt?
It carries real leverage — Khaitan Chemicals & Fertilizers Ltd's debt-to-equity is 1.05, and operating profit covers the interest bill 4×. FY26 borrowings were ₹306 Cr against equity of ₹291 Cr. Read the returns on this page with that leverage in mind — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's capex?
Khaitan Chemicals & Fertilizers Ltd spent ₹22.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹3.0 Cr, with ₹3.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Khaitan Chemicals & Fertilizers Ltd's cash flow?
Khaitan Chemicals & Fertilizers Ltd generated ₹44.0 Cr of operating cash flow in FY26 and ₹41.0 Cr of free cash flow after ₹3.0 Cr of capital spending. Reported profit that year was ₹65.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 0% of Khaitan Chemicals & Fertilizers Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹44.0 Cr against reported profit of ₹65.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 14 August 2026.
How financially safe is Khaitan Chemicals & Fertilizers Ltd?
On the balance sheet, the Z-score reads 4.05 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 14 August 2026.
Where is Khaitan Chemicals & Fertilizers Ltd in its business cycle?
Khaitan Chemicals & Fertilizers Ltd's FY26 operating margin was 11.0%, against a 13-year band of −6.0%–15.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 11.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Khaitan Chemicals & Fertilizers Ltd story?
The sharpest disagreement: annual EPS moved +4,657.1% against a −52.7% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Khaitan Chemicals & Fertilizers Ltd a stock worth studying right now?
This is not investment advice. The machine read: Khaitan Chemicals & Fertilizers Ltd is cheap for a reason. The P/E sits at the 17th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.